Mike Min
Founder at DKX Biosciences
New Haven, Connecticut, United States
Summary
👤
Senior🎓
Top SchoolMike Min is a seasoned life sciences entrepreneur and tenured professor with 25+ years of experience translating basic biology into preclinical therapeutics across cardiovascular, metabolic, ophthalmic, and oncologic diseases. As Founder of DKX Biosciences and former senior leader at Virscio and Yale School of Medicine, he has led industry-academic collaborations delivering proof-of-concept therapies—from gene delivery and antibodies to small molecules—validated in multiple mouse models. He combines deep mechanistic insight (ASK1 signaling, inflammasome, SUMOylation, mitophagy) with practical drug-development experience, including successful partnerships with Genentech, Gilead and biotech firms. Author on over 140 peer-reviewed papers, Mike is equally comfortable designing animal models and presenting preclinical data to industry stakeholders and investors. Based in New Haven, he leverages both academic rigor and commercial savvy to advance translational programs toward therapeutic candidates. An underappreciated strength is his track record of converting mechanistic discoveries into tangible pharmacological interventions across diverse disease areas.
11 years of coding experience
17 years of employment as a software developer
Ph.D Molecular Biology and Genetics, Ph.D Molecular Biology and Genetics at University of Wales, Swansea U.K.Postdoc Immunology, Postdoc Immunology at Yale School of Medicine
Github Skills (4)
github10
git10
location6
reddit5
Programming languages (2)
Github contributions (5)
SacrificialGoat/Boilerplace
Jul 2015 - Aug 2015
Contributions:80 commits, 45 PRs, 31 pushes in 12 days
locationsharingredditlocation-sharing
mikemsrk/Eliter
Mar 2015 - Aug 2015
Contributions:30 commits, 22 pushes, 1 branch in 5 months
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.